![\"imanova\"](\"https:\/\/blogs-staging.imperial.ac.uk\/fom\/files\/2014\/03\/imanova.jpg\")
<\/a><\/strong>Imanova Limited, the Centre for Imaging Sciences in London, has announced that six researchers from Imperial College London, King\u2019s College London and UCL are to receive IMPETus awards. The awards are designed to both encourage the wider use of imaging and to enable researchers new to the area to gather the data required for its inclusion in full grant applications. Following the success of a pilot PET programme in 2012, IMPETus has now been officially launched and includes awards to scientists investigating not only dementia, depression and neurodegeneration, but also obesity and autism.<\/p>\nThe researchers selected include Dr Paul Edison of Imperial College London whose research project will investigate the influence of obesity on neuroinflammation in Alzhiemer’s disease. The Imperial researcher was awarded the grant as a result of the outstanding scientific merit of his work and for his innovative use of existing tracers in novel research areas. The research will be carried out at Imanova\u2019s world class facilities in London.<\/p>\n
\u201cWe are delighted with the high calibre of experimental medicine studies for this year\u2019s PET programme at Imanova and look forward to supporting this work,\u201d announced Roger Gunn, CSO of Imanova Limited. \u201cWe believe that by providing access to our world-class imaging facilities, we can create an environment for sharing ideas, resources and expertise in imaging, whilst training and developing the next generation of imaging scientists and practitioners.\u201d<\/p>\n
The pilot studies from the initial round in 2012 can be found in Imanova\u2019s annual report: http:\/\/www.imanova.co.uk\/company\/annual-review\/<\/a><\/p>\n